Cellular Immunity to Bacteria: Impairment of in Vitro Lymphocyte Responses to Pseudomonas Aeruginosa in Cystic Fibrosis Patients.

Infection and Immunity - United States
doi 10.1128/iai.18.3.735-740.1977
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

The Susceptibility of Pseudomonas Aeruginosa Strains From Cystic Fibrosis Patients to Bacteriophages

PLoS ONE
Multidisciplinary
2013English

Development of Levofloxacin Inhalation Solution to Treat Pseudomonas Aeruginosa in Patients With Cystic Fibrosis

Therapeutic Advances in Respiratory Disease
PulmonaryRespiratory MedicinePharmacology
2013English

Eradication of Pseudomonas Aeruginosa in Cystic Fibrosis

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2006English

Immunization of Noncolonized Cystic Fibrosis Patients Against Pseudomonas Aeruginosa

Journal of Infectious Diseases
Infectious DiseasesAllergyImmunology
1994English

Treatment of Pseudomonas Aeruginosa Colonisation in Cystic Fibrosis.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1989English

Pseudomonas Aeruginosa in Cystic Fibrosis: A Chronic Cheater

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

Low Rates of Pseudomonas Aeruginosa Misidentification in Isolates From Cystic Fibrosis Patients

Journal of Clinical Microbiology
Microbiology
2009English

Antibody to Pseudomonas Aeruginosa Mucoid Exopolysaccharide and to Sodium Alginate in Cystic Fibrosis Serum

Pediatric Research
Child HealthPediatricsPerinatology
1984English

Relative Increase in IgG Antibodies to Pseudomonas Aeruginosa 60-kDa GroEL in Prediabetic Patients With Cystic Fibrosis

Pediatric Research
Child HealthPediatricsPerinatology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy